SCHEMBL413985

SCHEMBL413985

C=Cc1ccc(OCCCC)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.66
CHRNB4 P30926 1/20 0.66
CHRNA3 P32297 1/20 0.66
CHRNA7 P36544 1/20 0.66
CHRNA4 P43681 1/20 0.66
AHR P35869 1/20 0.54
LTA4H P09960 4/20 0.52
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NR5A1 Q13285 1/20 0.50
ALDH1A1 P00352 2/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL924891 0.96 CHRNB2 (0.62) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL4906796 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL19971166 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL10001376 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL2835258 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
Dimethylamine SCHEMBL3445816 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL2993153 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL19971155 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL2937499 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL2623206 0.94 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 581 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101308-A1 SEPARATOR FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME 삼성에스디아이 주식회사 2026-05-15 WO claimed
EP-4742412-A1 SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2026-05-13 EP claimed
US-20260128465-A1 SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2026-05-07 US claimed
US-20260128467-A1 SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2026-05-07 US claimed
CN-117467059-A Polymer porous microsphere and preparation method and application thereof 西安蓝晓科技新材料股份有限公司 2024-01-30 CN claimed
CN-115368523-A Multi-block thermoplastic elastomer and preparation method thereof 安徽农业大学 2022-11-22 CN claimed
CN-114539459-A Solid-phase synthesis carrier and preparation method and application thereof 西安蓝晓科技新材料股份有限公司 2022-05-27 CN claimed
US-11220062-B2 Water-dispersible thermoplastic material comprising sulfonated copolymer for use in additive manufacturing STRATASYS, INC. (US) 2022-01-11 US claimed
US-11202741-B2 Self-restorable core-shell capsule AMOREPACIFIC CORPORATION (KR) 2021-12-21 US claimed
CN-113690474-A Ultrathin low-permeability hydrogen proton exchange membrane and preparation method thereof 中北大学 2021-11-23 CN claimed
US-20200207025-A1 WATER-DISPERSIBLE THERMOPLASTIC MATERIAL COMPRISING SULFONATED COPOLYMER FOR USE IN ADDITIVE MANUFACTURING STRATASYS, INC. 2020-07-02 US claimed
US-7875285-B1 n acrylic ester polymer including a drug having anovercoating of a different acrylic ester polymer having a glass transition temperature of 35-50 degrees C. to control elution of the drug; temperature change morphology of drug polymer to change and increase release; thrombolytic agents; restenosis ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2011-01-25 US claimed
US-7141177-B2 Etching method and composition for forming etching protective layer AZ ELECTRONIC MATERIALS USA CORP. (US) 2006-11-28 US claimed
EP-0496405-A1 Porous resin and process for its production MITSUBISHI KASEI CORPORATION (JP) 1992-07-29 EP claimed
WO-2026101308-A1 SEPARATOR FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY COMPRISING SAME 삼성에스디아이 주식회사 2026-05-15 WO disclosed
EP-4742410-A1 SEPARATOR FOR RECHARGEABLE BATTERY AND RECHARGEABLE BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2026-05-13 EP disclosed
EP-4742412-A1 SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2026-05-13 EP disclosed
US-4413092-A ACRYLONITRILE-BUTADIENE-STYRENE AND A BLOCK THERMOPLASTIC ELASTOMER OCCIDENTAL CHEMICAL CORPORATION (US) 1983-11-01 US disclosed
US-4319002-A BUTADIENE-METHYL METHACRYLATE-STYRENE TERPOLYMER, BLOCK THERMOPLATIC ELASTOMER OF ALKENYL AROMATIC AND CONJUGATED ALKADIENE HOOKER CHEMICALS & PLASTICS CORP. (US) 1982-03-09 US disclosed
US-4192828-A Polymer compositions having enhanced low temprature impact resistance on ageing HOOKER CHEMICALS & PLASTICS CORP. (US) 1980-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260128465-A1 SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME MMAB, HAT1, CD44 CHRNB2 1065/4885CHRNB4 1423/4885CHRNA3 1835/4885
US-20260128467-A1 SEPARATOR FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SMCHD1, SMC4, L1CAM CHRNB2 1346/4885CHRNB4 1258/4885CHRNA3 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.